325 related articles for article (PubMed ID: 36990116)
1. [Clonal hematopoiesis of undetermined potential (CHIP) and clonal cytopenia of unknown significance (CCUS) - Consequences for the clinic].
Ziemann F; Metzeler KH
Dtsch Med Wochenschr; 2023 Apr; 148(8):441-450. PubMed ID: 36990116
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostics in unclear cytopenia-How and when do we screen for clonal hematopoiesis?].
Haferlach C; Heuser M
Inn Med (Heidelb); 2022 Nov; 63(11):1141-1147. PubMed ID: 36121473
[TBL] [Abstract][Full Text] [Related]
3. Premalignant Clonal Hematopoiesis (Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenia of Undetermined Significance).
Craven KE; Ewalt MD
Clin Lab Med; 2023 Dec; 43(4):565-576. PubMed ID: 37865503
[TBL] [Abstract][Full Text] [Related]
4. Review of clonal hematopoiesis, subtypes and its role in neoplasia and different morbidities.
Younes IE; Syler L; Hamed A
Leuk Res; 2023 Jul; 130():107307. PubMed ID: 37186988
[TBL] [Abstract][Full Text] [Related]
5. From clonal hematopoiesis to myeloid leukemia and what happens in between: Will improved understanding lead to new therapeutic and preventive opportunities?
Bewersdorf JP; Ardasheva A; Podoltsev NA; Singh A; Biancon G; Halene S; Zeidan AM
Blood Rev; 2019 Sep; 37():100587. PubMed ID: 31400824
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Challenge and Clinical Dilemma: The Long Reach of Clonal Hematopoiesis.
Osman A; Patel JL
Clin Chem; 2021 Aug; 67(8):1062-1070. PubMed ID: 34263288
[TBL] [Abstract][Full Text] [Related]
7. Clonal hematopoiesis of indeterminate potential and clonal cytopenias of undetermined significance: 2023 update on clinical associations and management recommendations.
Mangaonkar AA; Patnaik MM
Am J Hematol; 2023 Jun; 98(6):951-964. PubMed ID: 36938794
[TBL] [Abstract][Full Text] [Related]
8. Clonal Hematopoiesis: Origins and determinants of evolution.
Mendez LM; Patnaik MM
Leuk Res; 2023 Jun; 129():107076. PubMed ID: 37075557
[TBL] [Abstract][Full Text] [Related]
9. How I investigate Clonal cytogenetic abnormalities of undetermined significance.
Tang G; Medeiros LJ; Wang SA
Int J Lab Hematol; 2018 Aug; 40(4):385-391. PubMed ID: 29624895
[TBL] [Abstract][Full Text] [Related]
10. Exploring the Associations Between Clonal Hematopoiesis of Indeterminate Potential, Myeloid Malignancy, and Atherosclerosis.
Menendez-Gonzalez JB; Rodrigues NP
Methods Mol Biol; 2022; 2419():73-88. PubMed ID: 35237959
[TBL] [Abstract][Full Text] [Related]
11. When are idiopathic and clonal cytopenias of unknown significance (ICUS or CCUS)?
Osman AEWG
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):399-404. PubMed ID: 34889436
[TBL] [Abstract][Full Text] [Related]
12. Clinical manifestations of clonal hematopoiesis: What has SF3B1-mutant MDS taught us?
Todisco G; Moura PL; Hellström-Lindberg E
Semin Hematol; 2022 Jul; 59(3):150-155. PubMed ID: 36115692
[TBL] [Abstract][Full Text] [Related]
13. Cancer patients with clonal hematopoiesis die from primary malignancy or comorbidities despite higher rates of transformation to myeloid neoplasms.
Chien KS; Ong F; Kim K; Li Z; Kanagal-Shamanna R; DiNardo CD; Takahashi K; Montalban-Bravo G; Hammond D; Sasaki K; Pierce SA; Kantarjian HM; Garcia-Manero G
Cancer Med; 2024 Mar; 13(5):e7093. PubMed ID: 38497538
[TBL] [Abstract][Full Text] [Related]
14. Clonal hematopoiesis and associated diseases: A review of recent findings.
Asada S; Kitamura T
Cancer Sci; 2021 Oct; 112(10):3962-3971. PubMed ID: 34328684
[TBL] [Abstract][Full Text] [Related]
15. Defining clonal hematopoiesis of indeterminate potential: evolutionary dynamics and detection under aging and inflammation.
Goldman EA; Spellman PT; Agarwal A
Cold Spring Harb Mol Case Stud; 2023 Apr; 9(2):. PubMed ID: 36889927
[TBL] [Abstract][Full Text] [Related]
16. Molecular Pathways in Clonal Hematopoiesis: From the Acquisition of Somatic Mutations to Transformation into Hematologic Neoplasm.
Gaulin C; Kelemen K; Arana Yi C
Life (Basel); 2022 Jul; 12(8):. PubMed ID: 36013314
[TBL] [Abstract][Full Text] [Related]
17. A new risk factor associated with cardiovascular disease: clonal hematopoiesis of indeterminate potential.
Yu X; Qian N; Wang Y
Mol Biol Rep; 2023 Mar; 50(3):2813-2822. PubMed ID: 36595120
[TBL] [Abstract][Full Text] [Related]
18. Evolutionary landscape of clonal hematopoiesis in 3,359 individuals from the general population.
van Zeventer IA; de Graaf AO; Salzbrunn JB; Nolte IM; Kamphuis P; Dinmohamed A; van der Reijden BA; Schuringa JJ; Jansen JH; Huls G
Cancer Cell; 2023 Jun; 41(6):1017-1031.e4. PubMed ID: 37146604
[TBL] [Abstract][Full Text] [Related]
19. Advances in understanding the molecular basis of clonal hematopoiesis.
Alagpulinsa DA; Toribio MP; Alhallak I; Shmookler Reis RJ
Trends Mol Med; 2022 May; 28(5):360-377. PubMed ID: 35341686
[TBL] [Abstract][Full Text] [Related]
20. Current Aspects of Clonal Hematopoiesis: Implications for Clinical Diagnosis.
Karner K; George TI; Patel JL
Ann Lab Med; 2019 Nov; 39(6):509-514. PubMed ID: 31240877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]